The authors, indeed found a reduction of DCP in eyes with quiescent macular NV and intermediate AMD, while they report that in exudative AMD eyes, the perfusion density remained stable throughout follow-up, suggesting that anti-vascular endothelial growth factor (VEGF) injections do not impact on the perfusion of the DCP [22]. This evidence concerns the gene VEGFA and age-related macular degeneration.